FGF19 and hepatocellular carcinoma: Additionally, FGF19 is linked to the progression of hepatocellular carcinoma [50], and FGF23 mediates its effect by activating FGFR1c, FGFR3c, FGFR4, and the α-Klotho cofactor [51,52].